Post written by: BioTech Health X
You May Also Like
Corcept (CORT) Skyrockets 1,534% in 10 Years
- BioTech Health X
- October 1, 2025
- 6 minute read
Table of Contents Hide Corcept Therapeutics Delivers Strong Earnings but Tempers GuidanceNDA Filing for Relacorilant Marks a Pivotal…
HealthEquity (HQY) Crushes Earnings With 67% Profit Surge
- BioTech Health X
- September 3, 2025
- 6 minute read
Table of Contents Hide Financial Results Reflect Strong MomentumGrowth in HSA Accounts and AssetsLegislative Wins Unlock New Growth…
Ocean Biomedical (OCEA) Warned Over Missed $612,581 Milestone
- BioTech Health X
- September 17, 2025
- 5 minute read
Table of Contents Hide Ocean Biomedical Faces Setback but Retains Long-Term PotentialLicense Termination as a Reset PointPipeline Beyond…
SELLAS (SLS) Surged 40% After Hours on New AML Data
- BioTech Health X
- October 19, 2025
- 4 minute read
Table of Contents Hide Insider Buying Confirms Growing Confidence in Upcoming CatalystsHedge Funds and Institutional Investors Are Rapidly…
Ocugen Announces FDA Clinical Hold Removal for Phase 2/3 COVAXIN (BBV152) Clinical Trial
- BioTech Health X
- May 23, 2022
- 3 minute read
Table of Contents Hide About OcugenAbout COVAXIN (BBV152)COVAXIN (BBV152) Previous Clinical Holds Biotechnology company Ocugen, Inc. (NASDAQ: OCGN)…
Radiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise
- BioTech Health X
- October 15, 2025
- 7 minute read
Table of Contents Hide Trading Halt Signals a Major Financial Inflection PointA Robust Pipeline Poised for Multiple CatalystsFinancial…